Literature DB >> 32767225

Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?

Angelena Crown1, Shirin Muhsen2, Emily C Zabor3, Varadan Sevilimedu4, Joanne Kelvin5, Shari B Goldfarb6, Mary L Gemignani7.   

Abstract

BACKGROUND: The American Society of Clinical Oncology guidelines recommend early referral to reproductive endocrinology and infertility (REI) specialists for young women diagnosed with breast cancer. Current practice patterns demonstrate an increased utilization of neoadjuvant chemotherapy (NAC). We evaluated premenopausal women with breast cancer after consultation with a Fertility Nurse Specialist (FNS) and determine factors associated with referral to REI specialists.
METHODS: This retrospective review included all premenopausal women diagnosed at our institution with stage 0-III unilateral breast cancers between 2009 and 2015 who completed an FNS consultation. Clinicopathologic features and factors associated with referral to REI after FNS consultation were analyzed.
RESULTS: A total of 334 women were identified. Median age was 35 years (interquartile range 32-38). The majority of women were single (n = 198, 59.3%) and nulliparous (n = 239, 71.6%). REI referrals were common (n = 237, 71.0%). The Breast Surgery service was the most frequent referring service (n = 194, 58.1%), with significantly more REI referrals compared to Breast Medicine and Genetics services (p = 0.002). Nulliparity was associated with REI referral (p < 0.0001). Adjuvant chemotherapy (p = 0.003) was associated with pursuing REI referral, whereas NAC (p < 0.001) was associated with declining REI referral.
CONCLUSIONS: Most women elected to consult with an REI specialist, confirming strong interest in fertility preservation among premenopausal women with breast cancer. However, women receiving NAC more frequently declined referral to REI, suggesting that the need to start NAC may influence decisions regarding fertility preservation. With increasing utilization of NAC, our study supports the need for further counseling and education regarding fertility preservation for women undergoing NAC.

Entities:  

Mesh:

Year:  2020        PMID: 32767225      PMCID: PMC7554118          DOI: 10.1245/s10434-020-08883-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  53 in total

1.  Self-assessed knowledge of treatment and fertility preservation in young women with breast cancer.

Authors:  Angela M Jukkala; Andres Azuero; Pat McNees; G Wright Bates; Karen Meneses
Journal:  Fertil Steril       Date:  2010-05-05       Impact factor: 7.329

2.  Value of early referral to fertility preservation in young women with breast cancer.

Authors:  Sanghoon Lee; Sinan Ozkavukcu; Elke Heytens; Fred Moy; Kutluk Oktay
Journal:  J Clin Oncol       Date:  2010-09-27       Impact factor: 44.544

3.  How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.

Authors:  Anita Mamtani; Andrea V Barrio; Tari A King; Kimberly J Van Zee; George Plitas; Melissa Pilewskie; Mahmoud El-Tamer; Mary L Gemignani; Alexandra S Heerdt; Lisa M Sclafani; Virgilio Sacchini; Hiram S Cody; Sujata Patil; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2016-05-09       Impact factor: 5.344

4.  National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.

Authors:  Carlos A Puig; Tanya L Hoskin; Courtney N Day; Elizabeth B Habermann; Judy C Boughey
Journal:  Ann Surg Oncol       Date:  2016-12-20       Impact factor: 5.344

5.  Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.

Authors:  Kutluk Oktay; Volkan Turan; Giuliano Bedoschi; Fernanda S Pacheco; Fred Moy
Journal:  J Clin Oncol       Date:  2015-06-22       Impact factor: 44.544

6.  Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

Authors:  Gunter von Minckwitz; Michael Untch; Jens-Uwe Blohmer; Serban D Costa; Holger Eidtmann; Peter A Fasching; Bernd Gerber; Wolfgang Eiermann; Jörn Hilfrich; Jens Huober; Christian Jackisch; Manfred Kaufmann; Gottfried E Konecny; Carsten Denkert; Valentina Nekljudova; Keyur Mehta; Sibylle Loibl
Journal:  J Clin Oncol       Date:  2012-04-16       Impact factor: 44.544

7.  Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.

Authors:  Joseph M Letourneau; Nikita Sinha; Kaitlyn Wald; Eve Harris; Molly Quinn; Tal Imbar; Evelyn Mok-Lin; A Jo Chien; Mitchell Rosen
Journal:  Hum Reprod       Date:  2017-10-01       Impact factor: 6.918

Review 8.  Use of tamoxifen before and during pregnancy.

Authors:  Geert Braems; Hannelore Denys; Olivier De Wever; Veronique Cocquyt; Rudy Van den Broecke
Journal:  Oncologist       Date:  2011-10-21

9.  Adolescents and Young Adults with Breast Cancer have More Aggressive Disease and Treatment Than Patients in Their Forties.

Authors:  Brittany L Murphy; Courtney N Day; Tanya L Hoskin; Elizabeth B Habermann; Judy C Boughey
Journal:  Ann Surg Oncol       Date:  2019-08-02       Impact factor: 5.344

Review 10.  Breast cancer before age 40 years.

Authors:  Carey K Anders; Rebecca Johnson; Jennifer Litton; Marianne Phillips; Archie Bleyer
Journal:  Semin Oncol       Date:  2009-06       Impact factor: 4.929

View more
  4 in total

1.  ASO Author Reflections: Impact of Neoadjuvant Chemotherapy on Exploration of Fertility Preservation.

Authors:  Angelena Crown; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2020-08-09       Impact factor: 5.344

2.  Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes.

Authors:  Angelena Crown; Shirin Muhsen; Varadan Sevilimedu; Joanne Kelvin; Shari B Goldfarb; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2022-06-07       Impact factor: 4.339

3.  Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer.

Authors:  Erin Cordeiro; Amanda Roberts; Evelyne Guay
Journal:  Ann Surg Oncol       Date:  2021-11-26       Impact factor: 4.339

4.  The Virtual Scientific Sessions from the American Society of Breast Surgeons During the COVID-19 Pandemic.

Authors:  Henry M Kuerer; Sarah L Blair
Journal:  Ann Surg Oncol       Date:  2020-08-18       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.